Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors

Figure 3

Top 14 enrichment of GO terms and top 7 enrichment of KEGG pathways for 39 candidate genes.

(a)

(b)